Multipurpose prevention technologies, or MPTs, are products designed to simultaneously prevent HIV, other STIs, and/or unintended pregnancy. Internal and external condoms are the only MPTs currently available and, while effective, they are less than desirable for many sexually active humans on the planet. Humans need and deserve a suite of options, and the more types of protection an option provides, the more likely it will be used. The presenters shared updates and perspectives about the MPT research pipeline, focusing on the products closest to actual roll-out and implementation. This webinar was a collaboration between AIDS Foundation Chicago and AVAC, with funding provided by Merck.